X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs LUPIN - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LUPIN BIOCON /
LUPIN
 
P/E (TTM) x 40.9 46.6 87.8% View Chart
P/BV x 7.1 2.9 247.4% View Chart
Dividend Yield % 0.2 0.6 28.2%  

Financials

 BIOCON    LUPIN
EQUITY SHARE DATA
    BIOCON
Mar-18
LUPIN
Mar-18
BIOCON /
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,1881,465 81.1%   
Low Rs305727 41.9%   
Sales per share (Unadj.) Rs68.7349.6 19.7%  
Earnings per share (Unadj.) Rs7.65.6 135.9%  
Cash flow per share (Unadj.) Rs14.029.6 47.2%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %0.10.5 29.4%  
Book value per share (Unadj.) Rs86.3300.3 28.8%  
Shares outstanding (eoy) m600.00452.08 132.7%   
Bonus/Rights/Conversions ISESOPS-  
Price / Sales ratio x10.93.1 346.5%   
Avg P/E ratio x98.9197.2 50.1%  
P/CF ratio (eoy) x53.437.1 144.2%  
Price / Book Value ratio x8.63.6 236.9%  
Dividend payout %13.290.0 14.7%   
Avg Mkt Cap Rs m447,900495,502 90.4%   
No. of employees `0006.117.0 36.1%   
Total wages/salary Rs m9,31128,647 32.5%   
Avg. sales/employee Rs Th6,705.89,273.6 72.3%   
Avg. wages/employee Rs Th1,514.21,681.0 90.1%   
Avg. net profit/employee Rs Th736.9147.4 499.8%   
INCOME DATA
Net Sales Rs m41,234158,042 26.1%  
Other income Rs m2,0621,504 137.1%   
Total revenues Rs m43,296159,545 27.1%   
Gross profit Rs m8,29131,475 26.3%  
Depreciation Rs m3,85110,859 35.5%   
Interest Rs m6152,044 30.1%   
Profit before tax Rs m5,88720,076 29.3%   
Minority Interest Rs m213-71 -300.4%   
Prior Period Items Rs m035 0.0%   
Extraordinary Inc (Exp) Rs m0-14,644 0.0%   
Tax Rs m1,5692,885 54.4%   
Profit after tax Rs m4,5312,513 180.3%  
Gross profit margin %20.119.9 101.0%  
Effective tax rate %26.714.4 185.5%   
Net profit margin %11.01.6 691.2%  
BALANCE SHEET DATA
Current assets Rs m41,486122,095 34.0%   
Current liabilities Rs m21,41350,956 42.0%   
Net working cap to sales %48.745.0 108.1%  
Current ratio x1.92.4 80.9%  
Inventory Days Days6485 75.6%  
Debtors Days Days94120 78.5%  
Net fixed assets Rs m50,661129,876 39.0%   
Share capital Rs m3,000904 331.8%   
"Free" reserves Rs m48,808134,866 36.2%   
Net worth Rs m51,808135,771 38.2%   
Long term debt Rs m17,89864,245 27.9%   
Total assets Rs m99,897263,054 38.0%  
Interest coverage x10.610.8 97.7%   
Debt to equity ratio x0.30.5 73.0%  
Sales to assets ratio x0.40.6 68.7%   
Return on assets %5.21.7 297.4%  
Return on equity %8.71.9 472.6%  
Return on capital %9.63.7 259.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05853,141 22.7%   
Fx outflow Rs m7,34819,335 38.0%   
Net fx Rs m4,71033,807 13.9%   
CASH FLOW
From Operations Rs m6,62117,512 37.8%  
From Investments Rs m-6,840-14,073 48.6%  
From Financial Activity Rs m-2,397-14,921 16.1%  
Net Cashflow Rs m-2,612-11,482 22.7%  

Share Holding

Indian Promoters % 40.4 46.6 86.7%  
Foreign collaborators % 20.6 0.2 10,300.0%  
Indian inst/Mut Fund % 8.4 11.3 74.3%  
FIIs % 10.7 31.9 33.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 10.1 197.0%  
Shareholders   109,995 98,259 111.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   MERCK  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare BIOCON With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 490 Points Higher; Oil & Gas and Telecom Stocks Witness Buying(Closing)

Indian share markets continued to witness buying interest and ended their trading session on a positive note. Gains were largely seen in the oil & gas sector.

Related Views on News

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 24, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS